Compare DGII & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DGII | PBH |
|---|---|---|
| Founded | 1985 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | 1995 | 2004 |
| Metric | DGII | PBH |
|---|---|---|
| Price | $69.44 | $52.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $48.80 | ★ $75.33 |
| AVG Volume (30 Days) | 353.2K | ★ 447.1K |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.05 | N/A |
| EPS | ★ 1.00 | 0.61 |
| Revenue | $430,221,000.00 | ★ $975,777,000.00 |
| Revenue This Year | $18.71 | N/A |
| Revenue Next Year | $7.22 | $4.31 |
| P/E Ratio | ★ $69.31 | $85.61 |
| Revenue Growth | 1.46 | ★ 36.77 |
| 52 Week Low | $33.74 | $42.62 |
| 52 Week High | $86.84 | $71.07 |
| Indicator | DGII | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 37.96 | 52.92 |
| Support Level | $64.12 | $51.24 |
| Resistance Level | $70.30 | $53.11 |
| Average True Range (ATR) | 2.83 | 1.30 |
| MACD | -1.39 | 0.01 |
| Stochastic Oscillator | 10.02 | 59.00 |
Digi International Inc is a Minnesota corporation that provides business and mission-critical Internet of Things (IoT) connectivity products and services. It operates through two segments: IoT Products & Services, which supports OEMs, enterprise, and government customers in deploying secure IoT connectivity solutions, and IoT Solutions, consisting of SmartSense and its Managed Network-as-a-Service (MNaaS) business offering wireless temperature and condition-based monitoring, employee task management, label printing, and other services. The company generates the majority of its revenue from the IoT Products & Services segment and mainly from the United States, with a presence in Europe, the Middle East and Africa, and the Rest of the world.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.